Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1Condition 2
13percentage of study population developing mammary tumors during a period of timeBN/SsNHsdfemale0%17 beta-estradiol (27.5 mg) (between 196 and 199 days)6576517 beta-estradiol (27.5 mg) (between 196 and 199 days)
22percentage of study population developing mammary tumors during a period of timeACI/SegHsdfemale94%17 beta-estradiol (27.5 mg) (between 193 and 199 days)6576417 beta-estradiol (27.5 mg) (between 193 and 199 days)
14percentage of study population developing mammary tumors during a period of timeSS-Chr 3BN/Mcwifemale29%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655667,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
21percentage of study population developing mammary tumors during a period of timeACI/SegHsdfemale100%17 beta-estradiol (27.5 mg) (for 197 days)6554917 beta-estradiol (27.5 mg) (for 197 days)
7percentage of study population developing mammary tumors during a period of timeCOP/OlaHsdfemale43.8%17 beta-estradiol (27.5 mg) (between 212 and 330 days)6611317 beta-estradiol (27.5 mg) (between 212 and 330 days)
31percentage of study population developing mammary tumors during a period of timeACI/SegHsdfemale100%17 beta-estradiol (27.5 mg) (between 147 and 195 days)6611217 beta-estradiol (27.5 mg) (between 147 and 195 days)
13percentage of study population developing mammary tumors during a period of timeSS-Chr 5BN/Mcwifemale54%7,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days)114937,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days)
20percentage of study population developing mammary tumors during a period of timeSS-Chr 6BN/Mcwifemale20%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114947,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
40percentage of study population developing mammary tumors during a period of timeSS-Chr 9BN/Mcwifemale93%7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114957,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
3percentage of study population developing mammary tumors during a period of timeACI/SegHsdfemale0%control condition11378control condition
11percentage of study population developing mammary tumors during a period of timeACI/SegHsdfemale0%bilateral ovariectomy then 17 beta-estradiol (27.5 mg) (for 140 days)11379bilateral ovariectomy17 beta-estradiol (27.5 mg) (for 140 days)